4//SEC Filing
Sandberg Eric 4
Accession 0001179110-20-003908
CIK 0000805928other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:12 PM ET
Size
8.2 KB
Accession
0001179110-20-003908
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Sandberg Eric
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to purchase)
2020-03-16+24,000→ 24,000 totalExercise: $8.61Exp: 2030-03-16→ Common Stock (24,000 underlying) - Award
Restricted Stock Units
2020-03-16+12,000→ 12,000 total→ Common Stock (12,000 underlying)
Footnotes (3)
- [F1]All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2024 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F3]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001764446
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:12 PM ET
- Size
- 8.2 KB